Logo image
Breast Cancer Brain Metastasis Response to Radiation After Microbubble Oxygen Delivery in a Murine Model
Journal article   Open access   Peer reviewed

Breast Cancer Brain Metastasis Response to Radiation After Microbubble Oxygen Delivery in a Murine Model

Lauren J. Delaney, Lorela Ciraku, Brian E. Oeffinger, Corinne E. Wessner, Ji‐Bin Liu, Jingzhi Li, Kibo Nam, Flemming Forsberg, Dennis B. Leeper, Patrick O'Kane, …
Journal of ultrasound in medicine, v 38(12), pp 3221-3228
Dec 2019
PMID: 31124171
url
https://europepmc.org/articles/pmc7064157View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

contrast‐enhanced ultrasound hypoxia oxygen delivery radiosensitivity
Objectives Hypoxic cancer cells have been shown to be more resistant to radiation therapy than normoxic cells. Hence, this study investigated whether ultrasound (US)‐induced rupture of oxygen‐carrying microbubbles (MBs) would enhance the response of breast cancer metastases to radiation. Methods Nude mice (n = 15) received stereotactic injections of brain‐seeking MDA‐MB‐231 breast cancer cells into the right hemisphere. Animals were randomly assigned into 1 of 5 treatment groups: no intervention, 10 Gy radiation using a small‐animal radiation research platform, nitrogen‐carrying MBs combined with US‐mediated MB rupture immediately before 10 Gy radiation, oxygen‐carrying MBs immediately before 10 Gy radiation, and oxygen‐carrying MBs with US‐mediated MB rupture immediately before 10 Gy radiation. Tumor progression was monitored with 3‐dimensional US, and overall survival was noted. Results All groups except those treated with oxygen‐carrying MB rupture and radiation had continued rapid tumor growth after treatment. Tumors treated with radiation alone showed a mean increase in volume ± SD of 337% ± 214% during the week after treatment. Tumors treated with oxygen‐carrying MBs and radiation without MB rupture showed an increase in volume of 383% ± 226%. Tumors treated with radiation immediately after rupture of oxygen‐carrying MBs showed an increase in volume of only 41% ± 1% (P = 0.045), and this group also showed a 1 week increase in survival time. Conclusions Adding US‐ruptured oxygen‐carrying MBs to radiation therapy appears to delay tumor progression and improve survival in a murine model of metastatic breast cancer.

Metrics

16 Record Views
33 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Acoustics
Radiology, Nuclear Medicine & Medical Imaging
Logo image